Display options
Share it on

Dermatol Ther (Heidelb). 2015 Jun;5(2):117-27. doi: 10.1007/s13555-015-0077-2. Epub 2015 May 29.

Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey.

Dermatology and therapy

Thomas Dirschka, Giuseppe Micali, Linda Papadopoulos, Jerry Tan, Alison Layton, Simon Moore

Affiliations

  1. CentroDerm-Clinic, Wuppertal, Germany, [email protected].

PMID: 26022994 PMCID: PMC4470961 DOI: 10.1007/s13555-015-0077-2

Abstract

INTRODUCTION: Rosacea (including facial erythema) has a negative impact on psychological and emotional health. This survey aimed to assess the impact of facial erythema on subconscious perceptions and the initial reactions of others and how this affects attitudes in different settings. The survey also measured the impact of facial erythema on a person's emotional and psychological wellbeing.

METHODS: A total of 6831 participants from eight countries completed online computer-assisted web interviewing psychological assessments based on the implicit association test. Traditional questionnaires provided data on the impact of facial erythema and perceptions of people with rosacea from other participants.

RESULTS: Facial erythema was strongly associated with poor health and negative personality traits with participants reporting negative impacts of rosacea emotionally, socially and in the workplace. Nearly 80% reported difficulty in controlling facial erythema but those with physician-diagnosed rosacea had significantly improved control versus those with undiagnosed rosacea (39% vs 20%, p < 0.05).

CONCLUSIONS: People with facial erythema have to manage their own psychological barriers to cope with the disease and deal with the prejudice and negative first impressions of others. Formal diagnosis, advice and treatment from a healthcare professional improve rosacea control.

FUNDING: Galderma.

References

  1. N Engl J Med. 2005 Feb 24;352(8):793-803 - PubMed
  2. Health Soc Work. 1982 May;7(2):140-7 - PubMed
  3. J Health Psychol. 2005 Nov;10(6):821-9 - PubMed
  4. Am Health Drug Benefits. 2013 Jul;6(6):348-54 - PubMed
  5. Cognition. 2005 Feb;95(1):95-127 - PubMed
  6. Skin Therapy Lett. 2012 Dec;17(10):1-4 - PubMed
  7. Cutis. 1987 Jun;39(6):493-4 - PubMed
  8. Acta Derm Venereol. 2010 May;90(3):269-73 - PubMed
  9. Clin Psychol Psychother. 2012 Nov-Dec;19(6):488-95 - PubMed
  10. J Adv Nurs. 2006 Jan;53(2):221-32 - PubMed
  11. J Am Acad Dermatol. 2006 Sep;55(3):490-500 - PubMed
  12. Acta Derm Venereol. 2015 Apr;95(4):395-400 - PubMed
  13. Dermatology. 2008;217(2):169-72 - PubMed
  14. Acta Derm Venereol. 1989;69(5):419-23 - PubMed
  15. J Pers Soc Psychol. 1998 Oct;75(4):887-900 - PubMed
  16. Am J Public Health. 2012 May;102(5):979-87 - PubMed
  17. J Pers Soc Psychol. 1998 Jun;74(6):1464-80 - PubMed
  18. J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):401-7 - PubMed
  19. Am Fam Physician. 2002 Aug 1;66(3):435-40 - PubMed
  20. J Am Acad Dermatol. 2004 Jun;50(6):907-12 - PubMed

Publication Types